傑瑞股份(002353.SZ):新能源板塊鋰電池負極材料一期項目6.5萬噸產能基本建設完成
格隆匯8月15日丨傑瑞股份(002353.SZ)近期在接待機構投資者調研時表示,公司新能源板塊鋰電池負極材料一期項目6.5萬噸產能基本建設完成並已於3月初成功點火試生產。目前已取得了石墨化局部過程訂單和石墨負極成品訂單,併為相關客户穩定生產供貨。現階段,公司運用在高端裝備製造領域及環保領域所積攢的經驗,正在對負極材料工藝流程及設備進行升級優化改造,以期降本、提質、增效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.